Immune checkpoint inhibitors in first-line therapies of metastatic or early triple-negative breast cancer: a systematic review and network meta-analysis.
Frontiers in endocrinology（2023）
摘要
https://www.crd.york.ac.uk/PROSPERO/, identifier CRD42022354643.
更多查看译文
关键词
breast cancer,systematic review,first-line,triple-negative,meta-analysis
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要